An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
Completed
- Conditions
- Psoriasis
- Interventions
- Drug: Biologic Agent
- Registration Number
- NCT03964168
- Lead Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Brief Summary
Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
- Detailed Description
Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
- Male or female adults ≥ 18 years of age.
- Was receiving first or second biologic therapy
- Has not had a follow up with treating physician in ≥ 9 months
Exclusion Criteria
-
Actively receiving biologic therapy
- Was not receiving first or second biologic therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Biologic Therapy Biologic Agent Patient's who received and discontinued a biologic therapy
- Primary Outcome Measures
Name Time Method Determine the most common reason for discontinuation 5 years Tally number of patients who discontinued due to adverse events, insurance issues or category other.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Psoriasis Treatment Center of Central New Jersey
🇺🇸East Windsor, New Jersey, United States